Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Significant up-regulation of a novel gene, CLCP1, in a highly metastatic lung cancer subline as well as in lung cancers in vivo

Abstract

Most lung cancer patients are unfortunately uncurable and die because of widespread metastases, thus indicating the importance of identification of molecules with a crucial role in this process. Our previous expression profiling analysis of a highly metastatic lung cancer cell line, NCI-H460-LNM35, and its parental low metastatic line, NCI-H460-N15, revealed significant up-regulation of both known and unknown genes in LNM35. In this study, we describe the isolation and detailed characterizations of a novel gene, named CLCP1, which corresponds to one of such expression sequence tags with up-regulated expression in LNM35. The CLCP1 gene was found to encode a protein with 775 amino acids with structural similarities to, but distinct from neuropilins, cell surface receptors for VEGF165 and semaphorins. Notably, CLCP1 was shown to be up-regulated not only in LNM35 in association with its acquisition of metastatic phenotype during in vivo selection, but also in a significant fraction of lung cancers in vivo with high frequency in metastatic lesions, warranting future studies for a better understanding of the molecular mechanisms of lung cancer metastasis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Bachelder RE, Crago A, Chung J, Wendt MA, Shaw LM, Robinson G, Mercurio AM . 2001 Cancer Res. 61: 5736–5740

  • Bagnard D, Lohrum M, Uziel D, Puschel AW, Bolz J . 1998 Development 125: 5043–5053

  • Behar O, Golden JA, Mashimo H, Schoen FJ, Fishman MC . 1996 Nature 383: 525–528

  • Bork P, Beckmann G . 1993 J. Mol. Biol. 231: 539–545

  • Chen H, Chedotal A, He Z, Goodman CS, Tessier-Lavigne M . 1997 Neuron 19: 547–559

  • Fidler IJ, Kerbel RS, Ellis LM . 2001 Biology of Cancer: Angiogenesis: Cancer Principles and Practice of Oncology 6th edn DeVita Jr VT, Hellman S and Rosenberg SA (eds) Philadelphia: Lippincott Williams & Wilkins pp 917–925

    Google Scholar 

  • Frohman MA . 1993 Methods Enzymol. 218: 340–356

  • Fujisawa H, Kitsukawa T . 1998 Curr. Opin. Neurobiol. 8: 587–592

  • Hayashibara T, Yamada Y, Miyanashi T, Mori H, Joh T, Maeda T, Mori N, Maita T, Kamihira S, Tomonaga M . 2001 Clin. Cancer Res. 7: 2719–2726

  • He Z, Tessier-Lavigne M . 1997 Cell 90: 739–751

  • Kolodkin AL, Levengood DV, Rowe EG, Tai YT, Giger RJ, Ginty DD . 1997 Cell 90: 753–762

  • Kolodkin AL, Matthes DJ, Goodman CS . 1993 Cell 75: 1389–1399

  • Kozaki K, Koshikawa K, Tatematsu Y, Miyaishi O, Saito H, Hida T, Osada H, Takahashi T . 2001 Oncogene 20: 4228–4234

  • Kozaki K, Miyaishi O, Tsukamoto T, Tatematsu Y, Hida T, Takahashi T . 2000 Cancer Res. 60: 2535–2540

  • Liotta LA, Kohn EC . 2001 Nature 411: 375–379

  • Luo Y, Raible D, Raper JA . 1993 Cell 75: 217–227

  • Masood R, Cai J, Zheng T, Smith DL, Hinton DR, Gill PS . 2001 Blood 98: 1904–1913

  • Miao HQ, Klagsbrun M . 2000 Cancer Metas. Rev. 19: 29–37

  • Miao HQ, Lee P, Lin H, Soker S, Klagsbrun M . 2000 FASEB J. 14: 2532–2539

  • Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z . 1999 FASEB J. 13: 9–22

  • Sekido Y, Fong KM, Minna JD . 2001 Cancer of the Lung: Cancer Principles and Practice of Oncology 6th edn DeVita Jr VT, Hellman S and Rosenberg SA (eds) Philadelphia: Lippincott Williams & Wilkins pp 917–925

    Google Scholar 

  • Soker S, Kaefer M, Johnson M, Klagsbrun M, Atala A, Freeman MR . 2001 Am. J. Pathol. 159: 651–659

  • Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M . 1998 Cell 92: 735–745

  • Springer WR, Cooper DN, Barondes SH . 1984 Cell 39: 557–564

  • Statistics and Information Department, Minister's Secretariat 1999 Vital Statistics of Japan 1999 Vol. 3 Ministry of Health, Labour and Welfare: Tokyo pp 398–411

  • Stetler-Stevenson WG, Kleiner Jr DE . 2001 Molecular Biology of Cancer: Invasion and Metastasis: Cancer Principles and Practice of Oncology 6th edn DeVita Jr VT, Hellman S and Rosenberg SA (eds) Philadelphia: Lippincott Williams & Wilkins pp 123–136

    Google Scholar 

  • Trexler M, Banyai L, Patthy L . 2000 Eur. J. Biochem. 267: 5751–5757

  • Veikkola T, Karkkainen M, Claesson-Welsh L, Alitalo K . 2000 Cancer Res. 60: 203–212

Download references

Acknowledgements

The GenBank accession number for the CLCP1 cDNA is AB073146. This work was supported in part by a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology, Japan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Takashi Takahashi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Koshikawa, K., Osada, H., Kozaki, Ki. et al. Significant up-regulation of a novel gene, CLCP1, in a highly metastatic lung cancer subline as well as in lung cancers in vivo. Oncogene 21, 2822–2828 (2002). https://doi.org/10.1038/sj.onc.1205405

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205405

Keywords

This article is cited by

Search

Quick links